S-Acylthioethyl prodrugs of phosphonoformate

European Journal of Pharmaceutical Sciences

Volumn 5, Issue 4, 1997, Pages 199-208

  Briggs, Andrew D ^a   Camplo, Michel ^a   Freeman, Sally ^a   Lundström, Jan ^b   Pring, Brian G ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b Astra Arcus AB   (Sweden)

Author keywords

Antiviral; Foscarnet; Phosphonoformate; Prodrug; SATE

Indexed keywords

FOSCARNET; FOSCARNET DERIVATIVE; PRODRUG;

ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; ARTICLE; DRUG HYDROLYSIS; DRUG SYNTHESIS; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; LUNG FIBROBLAST; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0030980863     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(97)00281-9     Document Type: Article

References (31)

1. Barber, I., Rayner, B. and Imbach, J.-L. (1995) The prooligonucleotide approach. 1: Esterase-mediated reversibility of dithymidine S-alkyl-phosphorothiolates to dithymidine phosphorothioates. Bioorg. Med. Chem. Lett. 5, 563-568.
2. Benzaria, S., Gosselin, G., Pelicano, H., Maury, G., Aubertin, A.-M., Obert, G., Kirn, A. and Imbach, J.-L. (1995) New prodrugs of 9-(2-phosphonomethoxyethyl) adenine [PMEA]: synthesis and stability studies. Nucleosides Nucleotides 14, 563-565.
3. Briggs, A.D., Camplo, M., Freeman, S., Lundström, J. and Pring, B.G. (1996) Acyloxymethyl and 4-acyloxybenzyl diester prodrugs of phosphonoformate. Tetrahedron 52, 14937-14950.
4. Charvet, A.-S., Camplo, M., Faury, P., Graciet, J.-C., Mourier, N., Chermann, J.-C. and Kraus, J.-L. (1994) Inhibition of human immunodeficiency virus type 1 replication by phosphonoformate- and phosphonoacetate-2′,3′-dideoxy-3′-thiacytidine conjugates. J. Med. Chem. 37, 2216-2223.
5. Doi, T.T., Ma, Q.F., Rowley, G.L. and Kenyon, G.L. (1991) The synthesis of N-hydroxyphosphonoformamide, a potential antiviral agent: inhibition of HIV-1 reverse transcriptase. Med. Chem. Res. 1, 226-229.
6. Girardet, J.-L., Gosselin, G., Périgaud, C., Balzarini, J., De Clercq, E. and Imbach, J.-L. (1995) Synthesis and antitumor properties of some neutral triesters of 5-fluoro-2′-deoxyuridine-5′-monophosphate and 3′,5′-cyclic monophosphate. Nucleosides Nucleotides 14, 645-647.
7. Griengl, H., Hayden, W., Penn, G., De Clercq, E. and Rosenwirth, B. (1988) Phosphonoformate and phosphonoacetate derivatives of 5-substituted 2′-deoxyuridines: synthesis and antiviral activity. J. Med. Chem. 31, 1831-1839.
8. Hostetler, K.Y., Kini, G.D., Beadle, J.R., Aldern, K.A., Gardner, M.F., Border, R., Kumar, R., Barshak, L., Sridhar, C.N., Wheeler, C.J. and Richman, D.D. (1996) Lipid prodrugs of phosphonoacids: greatly enhanced antiviral activity of 1-O-octadecyl-sn-glycero-3-phosphonoformate in HIV-1, HSV-1 and HCMV-infected cells, in vitro. Antiviral Res. 31, 59-67.
9. Iyer, R.P., Phillips, L.R., Biddle, J.A., Thakker, D.R., Egan, W., Aoki, S. and Mitsuya, H. (1989) Synthesis of acyloxyalkyl acylphosphonates as potential prodrugs of the antiviral, trisodiun phosphonoformate (foscarnet sodium). Tetrahedron Lett. 30, 7141-7144.
10. Iyer, R.P., Boal, J.H., Phillips, L.R., Thakker, D.R. and Egan, W. (1994) Synthesis, hydrolytic behavior, and anti-HIV activity of selected acyloxyalkyl esters of trisodium phosphonoformate (foscarnet sodium). J. Pharm. Sci. 83, 1269-1273.
11. Krol, E.S., Davis, J.M. and Thatcher, G.R.J. (1991) Hydrolysis of phosphonoformate esters: product distribution and reactivity patterns. J. Chem. Soc., Chem. Commun., 118-119.
12. Krol, E.S. and Thatcher, G.R.J. (1993) Hydrolysis of phosphonoformate triesters: rate acceleration of a millionfold in nucleophilic substitution at phosphorus. J. Chem. Soc., Perkin Trans. 2, 793-794.
13. Lambert, R.W., Martin, J.A., Thomas, G.J., Duncan, I.B., Hall, M.J. and Heimer, E.P. (1989) Synthesis and antiviral activity of phosphonoacetic and phosphonoformic acid esters of 5-bromo-2′-deoxyuridine and related pyrimidine nucleosides and acyclonucleosides. J. Med. Chem. 32, 367-374.
14. Lefebvre, I., Périgaud, C., Pompon, A., Aubertin, A.-M., Girardet, J.-L., Kirn, A., Gosselin, G. and Imbach, J.-L. (1995a) Mononucleoside phosphotriester derivatives with S-acyl-2-thioethyl bioreversible phosphate-protecting groups: intracellular delivery of 3′-azido-2′,3′-dideoxythymidine 5′-monophosphate. J. Med. Chem. 38, 3941-3950.
15. Lefebvre, I., Pompon, A., Périgaud, C., Girardet, J.-L., Gosselin, G., Aubertin, A.-M., Kirn, A. and Imbach, J.-L. (1995b) Synthesis, decomposition pathways and in vitro evaluation of bioreversible phosphotriesters of AZT. Nucleosides Nucleotides 14, 763-766.
16. 5. Chem. Lett., 435-438.
17. Mitchell, A.G., Nicholls, D., Walker, I., Irwin, W.J. and Freeman, S. (1991) Prodrugs of phosphonoformate: Products, kinetics and mechanisms of hydrolysis of dibenzyl (methoxycarbonyl)phosphonate. J. Chem. Soc., Perkin Trans. 2, 1297-1303.
18. Mitchell, A.G., Nicholls, D., Irwin, W.J. and Freeman, S. (1992) Prodrugs of phosphonoformate: the effect of para-substituents on the products, kinetics and mechanism of hydrolysis of dibenzyl methoxycarbonylphosphonate. J. Chem Soc., Perkin Trans. 2, 1145-1150.
19. Norén, J.O., Helgstrand, E., Johansson, N.G., Misiorny, A. and Stening, G. (1983) Synthesis of esters of phosphonoformic acid and their antiherpes activity. J. Med. Chem. 26, 264-270.
20. Périgaud, C., Gosselin, G., Lefebvre, I., Girardet, J.-L., Benzaria, S., Barber, I. and Imbach, J.-L. (1993) Rational design for cytosolic delivery of nucleoside monophosphates: "SATE" and "DTE" as enzyme-labile transient phosphate protecting groups. Bioorg. Med. Chem. Lett. 3, 2521-2526.
21. Périgaud, C., Aubertin, A.-M., Benzaria, S., Pelicano, H., Girardet, J.-L., Maury, G., Gosselin, G., Kirn, A. and Imbach, J.-L. (1994) Equal inhibition of the replication of human immunodeficiency virus in human T-cell culture by ddA bis(SATE) phosphotriester and 3′-azido-2′,3′-dideoxythymidine. Biochem. Pharmacol. 48, 11-14.
22. Périgaud, C., Gosselin, G., Benzaria, S., Girardet, J.-L., Maury, G., Pélicano, H., Aubertin, A.-M., Kirn, A. and Imbach, J.-L. (1995) Bis(S-acyl-2-thioethyl)esters of 2′,3′- dideoxyadenosine 5′-monophosphate are potent anti-HIV agents in cell culture. Nucleosides Nucleotides 14, 789-791.
23. Pettersson, K.-J., Nordgren, T. and Westerlund, D. (1989) Determination of phosphonoformate (foscarnet) in biological fluids by ion-pair reversed-phase liquid chromatography. J. Chromatogr. 488, 447-455.
24. Pollack, S.J., Freeman, S., Pompliano, D.L. and Knowles, J.R. (1992) Cloning, overexpression and mechanistic studies of carboxyphosphonoenolpyruvate mutase from Streptomyces hygroscopicus. Eur. J. Biochem. 209, 735-743.
25. Puech, F., Gosselin, G., Lefebvre, I., Pompon, A., Aubertin, A.-M., Kirn, A. and Imbach, J.-L. (1993) Intracellular delivery of nucleoside monophosphates through a reductase-mediated activation process. Antiviral Res. 22, 155-174.
26. Vaghefi, M.M., McKernan, P.A. and Robins, R.K. (1986) Synthesis and antiviral activity of certain nucleoside 5′-phosphonoformate derivatives. J. Med. Chem. 29, 1389-1393.
27. Valette, G., Pompon, A., Girardet, J.-L., Cappellacci, L., Franchetti, P., Grifantini, M., La Colla, P., Loi, A.G., Périgaud, C., Gosselin, G. and Imbach, J.-L. (1996) Decomposition pathways and in vitro HIV inhibitory effects of iso ddA pronucleotides: toward a rational approach for intracellular delivery of nucleoside 5′- monophosphates. J. Med. Chem. 39, 1981-1990.
28. Wagstaff, A.J. and Bryson, H.M. (1994) Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections (Review). Drugs 48, 199-226.
29. Wahren, B., Harmenberg, J., Sundqvist, V.-A., Levén, B. and Sköldenberg, B. (1983) A novel method for determining the sensitivity of herpes simplex virus to antiviral compounds. J. Virol. Methods 6, 141-149.
30. Walker, I., Nicholls, D., Irwin, W.J. and Freeman, S. (1994) Drug delivery via active transport at the blood-brain barrier: affinity of a prodrug of phosphonoformate for the large amino acid transporter. Int. J. Pharm. 104, 157-167.
31. Zabik, M.J. and Schuetz, R.D. (1967) Product and rate studies on the reactions of selected aryl chloroformates with silver nitrate. J. Org. Chem. 32, 300-307.